Consumer and professional diagnostic tests manufactured by OraSure demonstrate exceptionally high clinical accuracy when utilized strictly according to manufacturer instructions. For instance, authorized rapid screening tools like the OraQuick HIV self-test exhibit high sensitivity and specificity in clinical trials, correctly identifying the vast majority of true positive and negative results, though package instructions emphasize that preliminary reactive results must always be confirmed via standard laboratory testing.